BG
AGN.PRA

BlackRock Group’s Allergan plc AGN.PRA Stock Holding History

BlackRock Group’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$32.6M Sell
42,785
-3,218
-7% -$2.43M 0.02% 691
2016
Q3 		$37.8M Sell
46,003
-5,309
-10% -$4.59M 0.02% 652
2016
Q2 		$42.8M Sell
51,312
-14,039
-21% -$11.7M 0.02% 614
2016
Q1 		$60.1M Sell
65,351
-1,232
-2% -$1.18M 0.03% 531
2015
Q4 		$68.5M Sell
66,583
-2,814
-4% -$2.83M 0.04% 491
2015
Q3 		$65.5M Buy
+69,397
New +$72.4M 0.04% 487

Other funds holding AGN.PRA

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.94B AUM 9.49% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BlackRock Group's AGN.PRA Position: Q4 2016 in Review

BlackRock Group reduced its Allergan plc (AGN.PRA) stake by 7% in Q4 2016, selling an estimated $2.43M and leaving 42,785 shares worth $32.6M. The position accounts for 0.02% of the portfolio, ranked #691.

BlackRock Group first reported a position in AGN.PRA in Q3 2015 and has held it in 6 quarters since. The position peaked at $68.5M in Q4 2015. 108 funds tracked by Wall St. Rank hold AGN.PRA as of Q4 2016.

  • BlackRock Group held 42,785 shares of Allergan plc worth $32.6M as of Q4 2016.
  • BlackRock Group sold 3,218 Allergan plc shares in Q4 2016, an estimated $2.43M.
  • Allergan plc made up 0.02% of BlackRock Group's portfolio in Q4 2016, its #691 holding.
  • BlackRock Group first reported a position in Allergan plc in Q3 2015 and has held it in 6 quarters since.
  • BlackRock Group's Allergan plc position peaked at $68.5M in Q4 2015.
  • 108 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.